Vertex Pharma's most recent trend suggests a bearish bias. One trading opportunity on Vertex Pharma is a Bear Call Spread using a strike $78.00 short call and a strike $83.00 long call offers a potential 7.53% return on risk over the next 4 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $78.00 by expiration. The full premium credit of $0.35 would be kept by the premium seller. The risk of $4.65 would be incurred if the stock rose above the $83.00 long call strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Vertex Pharma is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Vertex Pharma is bearish.
The RSI indicator is at 24.41 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Vertex Pharma
The Worst American Stocks of 2016
Wed, 07 Dec 2016 14:22:05 GMT
ETFs with exposure to Vertex Pharmaceuticals, Inc. : December 2, 2016
Fri, 02 Dec 2016 16:11:42 GMT
VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Change in Directors or Principal Officers
Fri, 02 Dec 2016 13:42:27 GMT
Is State Street Corp (STT) Going to Burn These Hedge Funds?
Thu, 01 Dec 2016 22:42:23 GMT
Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : VRTX-US : December 1, 2016
Thu, 01 Dec 2016 12:38:14 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook